NON-CNS TUMOR

Clinical trials for NON-CNS TUMOR explained in plain language.

Never miss a new study

Get alerted when new NON-CNS TUMOR trials appear

Sign up with your email to follow new studies for NON-CNS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Early trial halted: testing radiation plus new drug for tough cancers

Disease control Terminated

This early-stage trial tested whether combining a new drug called GEN1042 with radiation therapy, with or without another immunotherapy drug (pembrolizumab), is safe and can help shrink tumors in people with advanced solid cancers that have spread. The study was for adults whose …

Matched conditions: NON-CNS TUMOR

Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control

Last updated Apr 02, 2026 03:26 UTC

NON-CNS TUMOR

Get alerted when new NON-CNS TUMOR trials appear

Early trial halted: testing radiation plus new drug for tough cancers